Colony morphology switching of Candida lusitaniae and acquisition of multidrug resistance during treatment of a renal infection in a newborn: Case report and review of the literature

Diagnostic Microbiology and Infectious Disease

Volumn 47, Issue 1, 2003, Pages 331-339

  Favel, Anne ^a   Michel Nguyen, Annie ^b   Peyron, Florence ^a   Martin, Claude ^b   Thomachot, Laurent ^b   Datry, Annick ^c   Bouchara, Jean Philippe ^d   Challier, Svetlana ^e   Noël, Thierry ^f   Chastin, Christiane ^f   Regli, Patrick ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b HÔPITAL NORD   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

Author keywords

Candida lusitaniae; Colony morphology switching; Multidrug resistance; Renal infection

Indexed keywords

AMIKACIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CEFTAZIDIME; FLUCONAZOLE; METRONIDAZOLE; PIPERACILLIN; VANCOMYCIN;

ABDOMINAL DISTENSION; ANAMNESIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ASCITES; AUTOPSY; BLEEDING; BLOOD CULTURE; CANDIDA LUSITANIAE; CASE REPORT; CHILD DEATH; CLINICAL FEATURE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE CALCULATION; ECHOGRAPHY; EMPIRICISM; FATALITY; FUNGAL MORPHOLOGY; FUNGUS CULTURE; FUNGUS ISOLATION; HUMAN; INTRAUTERINE INFECTION; KIDNEY INFECTION; LABORATORY TEST; MALE; MICROMORPHOLOGY; MULTIDRUG RESISTANCE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SHORT COURSE THERAPY; THROMBOCYTOPENIA; URINE CULTURE; VERY LOW BIRTH WEIGHT;

EID: 0042328127     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(03)00094-4     Document Type: Article

References (61)

1. Alomar Y., Linas M.D., Lloverasm J.J., Becassem F., Durand D., Seguela J.P. Mycose systémique à Candida lusitaniae chez un malade néphrectomisé problèmes thérapeutiques . Bull Soc Fr Mycol Méd. XVIII:1989;113-116.
2. Baker J.G., Nadler H.L., Forgacs P., Kurtz S.R. Candida lusitaniae a new opportunistic pathogen of the urinary tract . Diagn Microbiol Infect Dis. 2:1964;145-149.
3. Barchiesi F., Tortorano A.M., Di Francesco L.F., Cogliati M., Scalise G., Viviani M.A. In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp. J Antimicrobial Chemother. 43:1999;295-299.
4. Behar S.M., Chertow G.M. Olecranon bursitis caused by infection with Candida lusitaniae. J Rheumatol. 25:1998;598-600.
5. Blinkhorn R.J., Adelhorn D., Spagnuolo P.J. Emergence of a new opportunistic pathogen Candida lusitaniae. J Clin Microbiol. 27:1989;236-240.
6. Bouchara J.P., Zouhair R., Le Boudouil S., Renier G., Filmon R., Chabasse D., Hallet J.N., Defontaine A. In-vivo selection of an azole-resistant petite mutant of Candida glabrata. J Med Microbiol. 49:2000;977-984.
7. Bradsher R.W., White F.J. Transient fungemia due to Candida lusitaniae. South Med J. 8:1985;626-627.
8. Christenson J.C., Guruswamy A., Mukwaya G., Rettig P.J. Candida lusitaniae an emerging human pathogen . Pediatr Infect Dis J. 6:1987;755-757.
9. Clancy C.J., Nguyen M.H., Yu V.L., Okoye F.E. Fungemia caused by Candida lusitaniae. Infect Med. 13:1996;940-951.
10. Di Lorenzo D.J., Wong G., Ludmir J. Candida lusitaniae chorioamnionitis in a bone marrow transplant patient. Obstetrics Gynecol. 90:1997;702-703.
11. Favel A., Michel-Nguyen A., Chastin C., Trousson F., Penaud A., Regli P. In vitro susceptibility pattern of Candida lusitaniae and evaluation of the E-test method. J Antimicrob Chemother. 39:1997;591-596.
12. Fowler S.L., Rhoton B., Springer S.C., Messer S.A., Hollis R.J., Pfaller M.A. Evidence for person-to-person transmission of Candida lusitaniae in a neonatal intensive care-unit. Infect Control Hosp Epidemiol. 5:1998;343-345.
13. François F., Noël T., Pépin R., Brulfert A., Chastin C., Favel A., Villard J. An alternative identification test relying upon the sexual reproduction ability of Candida lusitaniae strains isolated from hospitalized patients. J Clin Microbiol. 39:2001;3906-3914.
14. Garcia-Martos P., Diaz J., Castano M., Perez M., Marin P. Peritonitis caused by Candida lusitaniae in patient on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol. 36:1991;50.
15. Ghannoum M.A., Rice L.B. Antifungal agents mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance . Clin Microbiol Rev. 12:1999;501-517.
16. Ghannoum M.A., Swairjo I., Soll D.R. Variation in lipid and sterol contents in Candida albicans white and opaque phenotypes. J Med Vet Mycol. 28:1990;103-115.
17. Guinet R., Chanas J., Goullier A., Bonnefoy G., Ambroise-Thomas P. Fatal septicemia due to amphotericin B-resistant Candida lusitaniae. J Clin Microbiol. 18:1983;443-444.
18. Hadfield T.L., Smith M.B., Winn R.E., Rinaldi M.G., Guerra C. Mycoses caused by Candida lusitaniae. Rev Infect Dis. 9:1987;1006-1012.
19. Hawkins J.L., Baddour L.M. Candida lusitaniae infections in the era of fluconazole availability. Clin Infect Dis. 36:2003;14-18.
20. Khoory B.J., Vino L., Dall'Agnola A., Fanos V. Candida infections in newborns a review . J Chemother. 11:1999;367-378.
21. Kjaeldgaard P., Schultz S.H., Nielsen K., Stenderup J. Letal kateterseptikaemi med fund af Candida lusitaniae. Ugeskr Laege. 152:1990;611-612.
22. Kontoyiannis D.P. Modulation of fluconazole sensitivity by the interaction of mitochondria and erg3p in Saccharomyces cerevisiae. J Antimicrob Chemother. 46:2000;191-197.
23. Kossoff E.H., Buescher E.S., Karlowicz M.G. Candidemia in a neonatal intensive care-unit trends during fifteen years and clinical features of 111 cases . Pediatr Infect Dis J. 17:1998;504-508.
24. Kovacicova G., Hanzen J., Pisarcikova M., Sejnova D., Horn J., Babela R., Svetlansky I., Lovaszova M., Gogova M., Krcmery V. Nosocomial fungemia due to amphotericin B-resistant Candida spp. in three pediatric patients after previous neurosurgery for brain tumor. J Infect Chemother. 7:2001;45-48.
25. Krcmery V., Oravcova E., Spanik S., Mrazova-Studena M., Trupl J., Kunova A., Stopkova-Grey K., Kukuckova E., Krupova I., Demitrovicova A., Kralovicova K. Nosocomial breakthrough fungemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplasic chemotherapy analysis of aetiology risk factors and outcome . J Antimicrob Chemother. 41:1998;373-380.
26. Krcmery V., Mateicka F., Grausova S., Kunova A., Hanzen J. Invasive infections due to Clavispora lusitaniae. FEMS Immunol Med Microbiol. 23:1999;75-78.
27. Lecciones J.A., Lee J.W., Navarro E.E., Witebsky F.G., Marshall D., Steinberg S.M., Pizzo P.A., Walsh T.J. Vascular catheter-associated fungemia in patients with cancer analysis of 155 episodes . Clin Infect Dis. 14:1992;875-883.
28. Leggiadro R.J., Collins T. Postneurosurgical Candida lusitaniae meningitis. Pediatr Infect Dis J. 7:1988;368-369.
29. Libertin C.R., Wilson W.R., Roberts G.D. Candida lusitaniae, an opportunistic pathogen. Diagn Microbiol Infect Dis. 3:1985;69-71.
30. Mc Clenny N.B., Fei H., Baron E.J., Gales A.C., Houston A., Hollis R.J., Pfaller M.A. Change in colony morphology of Candida lusitaniae in association with development of amphotericin B resistance. Antimicrob Agents Chemother. 46:2002;1325-1328.
31. Merz W.G., Sandford G.R. Isolation and characterization of a polyene-resistant variant of Candida tropicalis. J Clin Microbiol. 9:1979;677-680.
32. Merz W.G. Candida lusitaniae frequency of recovery, colonization, infection, and amphotericin B resistance . J Clin Microbiol. 20:1984;1194-1195.
33. Merz W.G., Khazan U., Jabra-Rizk M.A., Osterhout G.J., Lehmann P.F. Strain delineation and epidemiology of Candida (Clavispora) lusitaniae. J Clin Microbiol. 30:1992;449-454.
34. Michel-Nguyen A., Favel A., Penaudm A., Penaudm A., Troussonm F., Carlottim A. Unusual case of Candida lusitaniae infection in a severely immunocompromised patient Multiple localizations of a single infective strain documented by restriction endonuclease analysis . J Mycol Méd. 6:1996;172-177.
35. Minari A., Hachem R., Raad I. Candida. lusitaniae a cause of breakthrough fungemia in cancer patient . Clin Infect Dis. 32:2001;186-190.
36. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard M27-A. 1997;National Committee for Clinical Laboratory Standards, Wayne, PA.
37. Nguyen M.H., Morris A.J., Dobson M.E., Snydman D.R., Peacock J.E., Rinaldi M.G., Yu V.L. Candida lusitaniae an important emerging pathogen. Infect Dis Clin Pract. 5:1996;273-278.
38. Odds F.C. Switch of phenotype as an escape mechanism of the intruder. Mycoses. 40:1997;9-12.
39. Oleinik A.M., Della-Latta P., Rinaldi M.G., Saiman L. Candida lusitaniae osteomyelitis in a premature infant. Am J Perinatolog. 10:1993;313-315.
40. Pappagianis D., Collins M.S., Hector R., Remington J. Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother. 16:1979;123-126.
41. Pensler M.I., Krawczyk P., Lebar W.D. Candida lusitaniae septicemia. Clin Microbiol Newslett. 7:1985;86-87.
42. Peyron F., Favel A., Michel-Nguyen A., Gilly M., Regli P., Bolmström A. Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest. J Clin Microbiol. 39:2001;339-342.
43. Peyron F., Favel A., Calaf R., Michel-Nguyen A., Bonaly R., Coulon J. Sterol and fatty acid composition of Candida lusitaniae clinical isolates. Antimicrob Agents Chemother. 46:2002;531-533.
44. Pfaller M.A., Messer S.A., Hollis R.J. Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae. Diagn Microbiol Infect Dis. 20:1994;127-133.
45. Pfaller M.A., Diekema D.J., Messer S.A., Boyken L., Hollis R.J., Jones R.N. In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J Clin Microbiol. 41:2003;78-83.
46. Pietrucha-Dilanchian P., Lewis R.E., Ahmad H., Lechin A.E. Candida lusitaniae catheter-related sepsis. Ann Pharmacother. 35:2001;1570-1574.
47. Powderly W.G., Kobayashi G.S., Herzig G.P., Medoff G. Amphotericin B-resistant yeast infection in severely immunocompromised patients. Am J Med. 84:1988;826-832.
48. Rex J.H., Walsh T.J., Sobel J.D., Filler S.G., Pappas P.G., Dismukes W.E., Edwards J.E. Practice guidelines for the treatment of candidiasis. Clin Infect Dis. 30:2000;662-678.
49. Sanchez P.J., Cooper B.H. Candida lusitaniae sepsis and meningitis in a neonate. Pediatr Infect Dis J. 6:1987;758-759.
50. Sarma P.S., Durairaj P., Padhye A.A. Candida lusitaniae causing fatal meningitis. Postgrad Med J. 69:1993;878-880.
51. Soll D.R., Galask R., Isley S., Rao T.V.G., Stone D., Hicks J., Schmid J., Mac K., Hanna C. 'Switching' of Candida albicans during successive episodes of reccurent vaginitis. J Clin Microbiol. 27:1989;681-690.
52. Sterling T.R., Merz W.G. Resistance to amphotericin B emerging clinical and microbiological patterns . Drug Res Updates. 1:1998;161-165.
53. St-Germain G., Laverdière M., Pelletier R., Bourgault A.M., Libman M., Lemieux C., Noël G. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada . J Clin Microbiol. 39:2001;949-953.
54. Terreni A.A., Strohecker J.S., Dowda H. Candida lusitaniae septicemia in a patient on extended home intravenous hyperalimentation. J Med Vet Mycol. 25:1986;63-65.
55. Thomas M.G., Parr D.H., Di Menna M., Lang S.D. Candida lusitaniae septicemia successful combination therapy . Clin Microbiol Newslett. 7:1985;142-143.
56. Vargas K., Messerm S.A., Pfaller M., Lockhart S.R., Stapleton J.T., Hellstein J., Soll D.R. Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode. J Clin Microbiol. 38:2000;3595-3607.
57. Vazquez J.A., Arganoza M.T., Boikov D., Yoon S., Sobel J.D., Akins R.A. Stable phenotypic resistance of Candida species to amphotericin B conferred by preexposure to subinhibitory levels of azoles. J Clin Microbiol. 36:1998;2690-2695.
58. Viudes A., Peman J., Canton E., Salavert M., Ubeda P., Lopez-Ribot J.L., Gobernado M. Two cases of fungemia due to Candida lusitaniae and a literature review. Eur J Clin Microbiol Infect Dis. 21:2002;294-299.
59. Wendt B., Haglund L., Razavi A., Rath R. Candida lusitaniae an uncommon cause of prosthetic valve endocarditis . Clin Infect Dis. 26:1998;769-770.
60. Yinnon A.M., Woodin K.A., Powell K.R. Candida lusitaniae infection in the newborn case report and review of the literature . Pediatr Infect Dis J. 11:1992;878-880.
61. Yoon S.A., Vazquez J.A., Steffan P.E., Sobel J.D., Akins R.A. High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates form amphotericin B susceptibility to resistance. Antimicrob Agents Chemother. 43:1999;836-845.